This program is intended for rheumatologists, rheumatology advanced practice providers, primary care physicians, advanced practice providers, and other healthcare professionals who care for patients with psoriatic arthritis and juvenile psoriatic arthritis.
Clinical Care Options, LLC (CCO) and the University of Cincinnati (UC) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO and UC policy. CCO and UC are committed to providing their learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Daniel Lovell, MD, MPH
Joseph E. Levinson Professor of Pediatrics
Division of Rheumatology
Department of Pediatrics
Cincinnati Childrens Hospital Medical Center
Daniel Lovell, MD, MPH: consultant: Abbott, AstraZeneca, GlaxoSmithKline, NIH-NIAMS, Novartis, Pfizer, United Bioscience Corporation; advisor: Pfizer; researcher: AbbVie, Bristol-Myers Squibb, Janssen, NIH/NICHD, Novartis, Roche.
Pamela Weiss, MD, MSCE
Associate Professor of Pediatrics and Epidemiology
Childrens Hospital of Philadelphia
Pamela Weiss, MD, MSCE: consultant/advisor/speaker: Lilly, Novartis, Pfizer; researcher: PCORI, NIH, Spondylitis Association of America.
The planners and content peer reviewers from Clinical Care Options, LLC and the University of Cincinnati do not have any relevant financial relationships to disclose.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Cincinnati designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 26, 2023, through January 25, 2024:
1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
This program has been made available online.
The goal of this activity is to improve the knowledge and competence of rheumatologists, rheumatology advanced practice providers, and other healthcare professionals to equip themselves and their patients with skills and information to alleviate patient burden and improve disease outcomes.